The efficacy and safety of donafenib combined with transcatheter arterial chemoembolization and anti-PD-1 antibodies as first-line therapy for hepatocellular carcinoma: A retrospective study

被引：0
|
作者：
Song, Danjun
Hao, Weiyuan
Cao, Fei
Luo, Jun
Guo, Liwen
Zhang, Zhewei
Zheng, Jiaping
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Dept Intervent Radiol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16178
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study
    Jian-Xu Li
    Wen-Xiang Deng
    Shi-Ting Huang
    Xiao-Feng Lin
    Mei-Ying Long
    Jie Zhang
    Ting-Shi Su
    Li-Qing Li
    Ya-Dan Pang
    Chun-Feng Liang
    Hong-Mei Zhou
    Hai-Yan Lu
    Shi-Xiong Liang
    Bang-De Xiang
    Radiation Oncology, 17
  • [42] Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study
    Guo, Wenbo
    Chen, Song
    Wu, Zhiqiang
    Zhuang, Wenquan
    Yang, Jianyong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [43] EFFICACY AND SAFETY OF LENVATINIB COMBINED WITH DIFFERENT ANTI-PD-1 ANTIBODY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL WORLD EVIDENCE BASED RETROSPECTIVE STUDY
    Chen, Bowen
    Zhang, Linzhi
    Cheng, Jiamin, Sr.
    Yan, Tao
    Lu, Yinying
    HEPATOLOGY, 2021, 74 : 637A - 638A
  • [44] Efficacy and Safety of PD-1 Inhibitors and Targeted Drugs Combined with Radiotherapy in First-Line Treatment of Oligometastatic Hepatocellular Carcinoma
    Zhu, K.
    Liu, J.
    Dou, X.
    Zhang, X.
    Xu, L.
    Shi, P.
    Shi, F.
    Yue, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E509 - E509
  • [45] Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study
    Jiang, Xiumei
    Wang, Pan
    Su, Ke
    Li, Han
    Chi, Hao
    Wang, Fei
    Liu, Yu
    Xu, Ke
    ANNALS OF HEPATOLOGY, 2025, 30 (02)
  • [46] Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion
    Zhao, Yuting
    Zhu, Xianggao
    Wang, Hongzhi
    Dong, Dezuo
    Gao, Song
    Zhu, Xu
    Wang, Weihu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [47] Original Article Efficacy and safety of transcatheter arterial chemoembolization combined with sorafenib and sintilimab in the treatment of unresectable hepatocellular carcinoma
    Zhang, Jian-Bo
    Wei, Liu
    Tang, Hui
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (12): : 7849 - 7858
  • [48] Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Deng, Liwei
    Sun, Yanyuan
    Wang, Haiqing
    Liao, Changli
    Li, Deshan
    Xu, Guohui
    Yang, Xuegang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 29 - 38
  • [49] Combination of transcatheter arterial chemoembolization and anti-PD-L1 liposomes therapy suppressed hepatocellular carcinoma progression in mice
    Li, Jie
    Zhang, Lijuan
    Tao, Yun
    Sun, Zongqiong
    Ge, Yuxi
    Hu, Shudong
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 189
  • [50] Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
    Yu, Bingran
    Zhang, Ning
    Feng, Yun
    Zhang, Yongfa
    Zhang, Ti
    Wang, Lu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1735 - 1748
12345